UK Biopharmaceutical Biz Raises $260M In Series C Funding
British biopharmaceutical company Apollo Therapeutics revealed Tuesday that it completed a second close of its Series C financing round last month, bringing the total amount raised in the funding round over...To view the full article, register now.
Already a subscriber? Click here to view full article